標(biāo)題: Titlebook: Chronic Myeloid Neoplasias and Clonal Overlap Syndromes; Epidemiology, Pathop Richard Greil,Lisa Pleyer,Daniel Neureiter Book 2010 Springer [打印本頁(yè)] 作者: tricuspid-valve 時(shí)間: 2025-3-21 19:56
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes影響因子(影響力)
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes影響因子(影響力)學(xué)科排名
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes被引頻次
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes被引頻次學(xué)科排名
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes年度引用
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes年度引用學(xué)科排名
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes讀者反饋
書(shū)目名稱Chronic Myeloid Neoplasias and Clonal Overlap Syndromes讀者反饋學(xué)科排名
作者: curettage 時(shí)間: 2025-3-21 21:01
Diktumscharakterisierung als Sprechakt?,id WHO-classification of MDS, .). Approximately 1/3 of all MDS patients, more so patients with advanced stage MDS such as RAEB-I and RAEB-II, eventually progress to overt acute myeloid leukemia (AML). One might argue, that the terminus “myelodysplasia” was ill-chosen to denote a clonal neoplastic st作者: magenta 時(shí)間: 2025-3-22 01:55 作者: Increment 時(shí)間: 2025-3-22 05:09
Chronic Myeloid Neoplasias and Clonal Overlap SyndromesEpidemiology, Pathop作者: 托人看管 時(shí)間: 2025-3-22 09:16 作者: Parameter 時(shí)間: 2025-3-22 16:33 作者: Parameter 時(shí)間: 2025-3-22 18:01
Myelodysplastic Syndromes (MDS),id WHO-classification of MDS, .). Approximately 1/3 of all MDS patients, more so patients with advanced stage MDS such as RAEB-I and RAEB-II, eventually progress to overt acute myeloid leukemia (AML). One might argue, that the terminus “myelodysplasia” was ill-chosen to denote a clonal neoplastic st作者: 羊齒 時(shí)間: 2025-3-22 21:52 作者: 注視 時(shí)間: 2025-3-23 02:58
Book 2010of myeloproliferative dis- Each chapter follows a similar architecture and leads orders has substantially improved in the last few years. through epidemiology, genetic and molecular causes, Together with refined tools in pathology, the successful hematological and clinical findings, prognostic facto作者: PATRI 時(shí)間: 2025-3-23 06:17 作者: Ceramic 時(shí)間: 2025-3-23 13:45 作者: 開(kāi)始發(fā)作 時(shí)間: 2025-3-23 15:51
,Introduction to “Classic” Chronic Myeloproliferative Disorders (CMPDs) — Molecular and Cellular BioPDs and non-clonal benign and malignant hematopoietic disorders on the other hand. (2) The initial lack of clonal molecular diagnostic markers in the pre-JAK2 era, as well as the previous lack of clear-cut diagnostic criteria and an adequate classification system, has often led to misclassification of chronic myeloproliferative disorders.作者: 經(jīng)典 時(shí)間: 2025-3-23 18:09
Chronic myelogenous leukemia (CML),anagement of treatment failure, surveys results with approved second generation Abl kinase inhibitors after imatinib failure, and finally gives an outlook for promising treatment strategies examined in current and future clinical trials.作者: needle 時(shí)間: 2025-3-24 00:09
ent.Well illustrated with clinical photos, clear graphics anIntroduction The understanding of the genetic, epigenetic, immuno- well as for practicing hematologists or oncologists. logical and biological causes of myeloproliferative dis- Each chapter follows a similar architecture and leads orders ha作者: mortuary 時(shí)間: 2025-3-24 02:42 作者: 愉快嗎 時(shí)間: 2025-3-24 10:03 作者: 貪婪性 時(shí)間: 2025-3-24 14:40
https://doi.org/10.1057/978-1-137-54642-5s one extreme end of this spectrum, characterized by maximal clonal/oligoclonal T-cell proliferation, as LGL-like immunodominant cytotoxic lymphocyte (CTL) clonotypes are found within the whole spectrum of this continuum of overlap syndromes [.].作者: Thyroiditis 時(shí)間: 2025-3-24 15:21
Primary Myelofibrosis (PMF) [Previously Chronic Idiopathic Myelofibrosid (CIMF), Myelofibrosis withse disease (PMF-BP, post-PV/ET MF in blast phase). However, the recent change in nomenclature from chronic idiopathic myelofibrosis to primary myelofibrosis [.] is of questionable benefit at best, as well as inexact and confusing, considering that biologically, there is no such thing as “primary” myelofibrosis [.].作者: Airtight 時(shí)間: 2025-3-24 20:46
Chronic Myelomonocytic Leukemia (CMML),urse of their disease and ultimately progress to CMML [.]. Approximately one-fifth of patients with MDS present with a monocyte count of above 10% in the peripheral blood without fulfilling the FAB/WHO criteria for the diagnosis of CMML. A high incidence of disease progression to CMML has been reported for this subgroup [.] (see .).作者: 手榴彈 時(shí)間: 2025-3-24 23:30
Clonal Bone Marrow Failure Overlap Syndromes,s one extreme end of this spectrum, characterized by maximal clonal/oligoclonal T-cell proliferation, as LGL-like immunodominant cytotoxic lymphocyte (CTL) clonotypes are found within the whole spectrum of this continuum of overlap syndromes [.].作者: bifurcate 時(shí)間: 2025-3-25 04:24 作者: 喊叫 時(shí)間: 2025-3-25 07:40
Thomas Kron,Christian W. G. Lasarczykn platelets in the peripheral blood, with ensuing thrombohemorrhagic symptoms. Furthermore, mild leukocytosis, lack of hepatosplenomegaly and excellent prognosis with only rare transformation to acute leukemia are typical characteristics of this disease.作者: Nutrient 時(shí)間: 2025-3-25 14:13
Thomas Kron,Christian W. G. LasarczykPV in the state of Connecticut is 22 per 100,000 [.]. Only ～5% of the patients are <40 years at diagnosis. Several studies report a higher incidence in males. The prevalence is ～30/100,000. The incidence of thrombosis is ～18 per 1,000 person-years [.]. If left untreated, the survival time of patient作者: Phenothiazines 時(shí)間: 2025-3-25 16:58 作者: 工作 時(shí)間: 2025-3-25 22:30 作者: 談判 時(shí)間: 2025-3-26 02:07
Diktumscharakterisierung als Sprechakt?,s. MDS is characterized by an increased but ineffective and dysplastic hematopoiesis as well as peripheral cytopenias. The abnormal hematopoietic clone partly gives rise to mature, but functionally and morphologically abnormal blood cells, and, at least in some cases, is capable of both myeloid and 作者: fastness 時(shí)間: 2025-3-26 04:23 作者: 贊成你 時(shí)間: 2025-3-26 08:44
https://doi.org/10.1057/978-1-137-54642-5yeloid leukemia (CML) are relatively rare disorders. Due to the long life span of most patients with these diseases however, the prevalence is quite high, so that patients with these diseases are commonly seen in hematological outpatient departments.作者: 駕駛 時(shí)間: 2025-3-26 14:31
https://doi.org/10.1057/978-1-137-54642-5t can be present in adolescence or childhood on rare occasions [.]. Overall both genders are affected in approximately equivalent numbers. However, some Asian studies report a strong male preponderance [.]. The median age at diagnosis is 30 years in Caucasians and 45 years in Asian patients [.].作者: 配偶 時(shí)間: 2025-3-26 17:18
https://doi.org/10.1057/978-1-137-54642-5hemoglobinuria (PNH) and T-cell large granular lymphocytic leukemia (T-LGL) (see .). All these entities are bone marrow failure disorders1 in which oligoclonal T-cell-mediated immune responses are without doubt pathophysiologically relevant. These overlap syndromes seem to form some kind of disease-作者: crescendo 時(shí)間: 2025-3-27 00:07
https://doi.org/10.1007/978-3-211-79892-8Myelodysplastic Syndroms; Myeloproliferative Disorders; Myeolid Disorders; Therapy; anemia; cell; epidemio作者: 狂熱文化 時(shí)間: 2025-3-27 03:26
978-3-7091-2003-3Springer-Verlag Vienna 2010作者: FOLLY 時(shí)間: 2025-3-27 05:57
Thomas Kron,Christian W. G. Lasarczykn platelets in the peripheral blood, with ensuing thrombohemorrhagic symptoms. Furthermore, mild leukocytosis, lack of hepatosplenomegaly and excellent prognosis with only rare transformation to acute leukemia are typical characteristics of this disease.作者: genesis 時(shí)間: 2025-3-27 09:51
https://doi.org/10.1057/978-1-137-54642-5yeloid leukemia (CML) are relatively rare disorders. Due to the long life span of most patients with these diseases however, the prevalence is quite high, so that patients with these diseases are commonly seen in hematological outpatient departments.作者: 休戰(zhàn) 時(shí)間: 2025-3-27 16:36
https://doi.org/10.1057/978-1-137-54642-5t can be present in adolescence or childhood on rare occasions [.]. Overall both genders are affected in approximately equivalent numbers. However, some Asian studies report a strong male preponderance [.]. The median age at diagnosis is 30 years in Caucasians and 45 years in Asian patients [.].作者: 臭了生氣 時(shí)間: 2025-3-27 21:49 作者: 偉大 時(shí)間: 2025-3-28 01:35 作者: Assemble 時(shí)間: 2025-3-28 05:47
Essential Thrombocythemia (ET),n platelets in the peripheral blood, with ensuing thrombohemorrhagic symptoms. Furthermore, mild leukocytosis, lack of hepatosplenomegaly and excellent prognosis with only rare transformation to acute leukemia are typical characteristics of this disease.作者: 鐵砧 時(shí)間: 2025-3-28 08:17
Rare Clonal Myeloid Diseases,yeloid leukemia (CML) are relatively rare disorders. Due to the long life span of most patients with these diseases however, the prevalence is quite high, so that patients with these diseases are commonly seen in hematological outpatient departments.作者: artless 時(shí)間: 2025-3-28 13:13
,, “Classic” Paroxysmal Nocturnal Hemoglobinuria (PNH) (Marchiafava-Micheli Syndrome),t can be present in adolescence or childhood on rare occasions [.]. Overall both genders are affected in approximately equivalent numbers. However, some Asian studies report a strong male preponderance [.]. The median age at diagnosis is 30 years in Caucasians and 45 years in Asian patients [.].作者: Outmoded 時(shí)間: 2025-3-28 16:55 作者: 微不足道 時(shí)間: 2025-3-28 21:31 作者: 拾落穗 時(shí)間: 2025-3-28 22:59 作者: 使高興 時(shí)間: 2025-3-29 03:58
Primary Myelofibrosis (PMF) [Previously Chronic Idiopathic Myelofibrosid (CIMF), Myelofibrosis withibrosis Research and Treatment (IWG-MRT) convened in April and November 2006 to clarify definition, response criteria and nomenclature of this condition [.]. The term primary myelofibrosis (PMF) was chosen over several other designations including chronic idiopathic myelofibrosis (CIMF), agnogenic m作者: Meager 時(shí)間: 2025-3-29 09:52
